Alzheimer drug controversy

An existing Alzheimer drug has prompted a lawsuit from the New York State Attorney General, accusing a major drug maker of manipulating patients by forcing them to switch medications so the company makes more money.

This entry was posted in Biotech & Pharmaceuticals, NBR Show Clips. Bookmark the permalink.

Leave a Reply